Home
>
National Drug Code (NDC)
>
NEUPOGEN
NEUPOGEN - 55513-209-10 - (Filgrastim)
Drug Information of NEUPOGEN
| Product NDC: | 55513-209 |
| Proprietary Name: | NEUPOGEN |
| Non Proprietary Name: | Filgrastim |
| Active Ingredient(s): | 480 ug/.8mL & nbsp; Filgrastim |
| Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of NEUPOGEN
| Product NDC: | 55513-209 |
| Labeler Name: | Amgen Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103353 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20001002 |
Package Information of NEUPOGEN
| Package NDC: | 55513-209-10 |
| Package Description: | 10 SYRINGE in 1 BOX (55513-209-10) > .8 mL in 1 SYRINGE (55513-209-01) |
NDC Information of NEUPOGEN
| NDC Code | 55513-209-10 |
| Proprietary Name | NEUPOGEN |
| Package Description | 10 SYRINGE in 1 BOX (55513-209-10) > .8 mL in 1 SYRINGE (55513-209-01) |
| Product NDC | 55513-209 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Filgrastim |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20001002 |
| Marketing Category Name | BLA |
| Labeler Name | Amgen Inc |
| Substance Name | FILGRASTIM |
| Strength Number | 480 |
| Strength Unit | ug/.8mL |
| Pharmaceutical Classes | Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] |
